231 related articles for article (PubMed ID: 16923613)
21. Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts unselected PBPC grafts or BM grafts.
Behringer D; Bertz H; Schmoor C; Berger C; Dwenger A; Finke J
Bone Marrow Transplant; 1999 Aug; 24(3):295-302. PubMed ID: 10455369
[TBL] [Abstract][Full Text] [Related]
22. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.
Bethge WA; Haegele M; Faul C; Lang P; Schumm M; Bornhauser M; Handgretinger R; Kanz L
Exp Hematol; 2006 Dec; 34(12):1746-52. PubMed ID: 17157172
[TBL] [Abstract][Full Text] [Related]
23. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
24. CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients.
Ringhoffer M; Wiesneth M; Harsdorf S; Schlenk RF; Schmitt A; Reinhardt PP; Moessner M; Grimminger W; Mertens T; Reske SN; Döhner H; Bunjes D
Br J Haematol; 2004 Aug; 126(4):527-35. PubMed ID: 15287946
[TBL] [Abstract][Full Text] [Related]
25. Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells add-back.
Rodríguez-Luaces M; Ferrá C; Martín-Henao G; Berlanga JJ; Grañena A; Gallardo D
Eur J Haematol; 2004 Sep; 73(3):162-8. PubMed ID: 15287912
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic CD34+ -selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases.
Kremens B; Basu O; Peceny R; Grosse-Wilde H; Schaefer UW; Havers W
Bone Marrow Transplant; 2002 Jan; 29(1):9-13. PubMed ID: 11840138
[TBL] [Abstract][Full Text] [Related]
27. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
28. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.
Handgretinger R; Klingebiel T; Lang P; Schumm M; Neu S; Geiselhart A; Bader P; Schlegel PG; Greil J; Stachel D; Herzog RJ; Niethammer D
Bone Marrow Transplant; 2001 Apr; 27(8):777-83. PubMed ID: 11477433
[TBL] [Abstract][Full Text] [Related]
29. Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases.
Lang P; Klingebiel T; Bader P; Greil J; Schumm M; Schlegel PG; Eyrich M; Mueller-Weihrich S; Niethammer D; Handgretinger R
Bone Marrow Transplant; 2004 Jan; 33(1):25-32. PubMed ID: 14704654
[TBL] [Abstract][Full Text] [Related]
30. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
[TBL] [Abstract][Full Text] [Related]
31. Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias.
Bunin N; Aplenc R; Grupp S; Pierson G; Monos D
Bone Marrow Transplant; 2006 Jan; 37(2):143-9. PubMed ID: 16284615
[TBL] [Abstract][Full Text] [Related]
32. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect.
Díez-Martín JL; Gómez-Pineda A; Serrano D; Carrión R; Balsalobre P; Buño I
Bone Marrow Transplant; 2004 May; 33(10):1037-41. PubMed ID: 15064692
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.
Novitzky N; Thomas V; Stubbings H; Hale G; Waldmann H
Cytotherapy; 2004; 6(5):450-6. PubMed ID: 15512911
[TBL] [Abstract][Full Text] [Related]
35. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.
Klyuchnikov E; El-Cheikh J; Sputtek A; Lioznov M; Calmels B; Furst S; Chabannon C; Crocchiolo R; Lemarié C; Faucher C; Bacher U; Alchalby H; Stübig T; Wolschke C; Ayuk F; Reckhaus ML; Blaise D; Kröger N
Biol Blood Marrow Transplant; 2014 Mar; 20(3):382-6. PubMed ID: 24321747
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation.
Rieger K; Marinets O; Fietz T; Körper S; Sommer D; Mücke C; Reufi B; Blau WI; Thiel E; Knauf WU
Exp Hematol; 2005 May; 33(5):605-11. PubMed ID: 15850839
[TBL] [Abstract][Full Text] [Related]
37. T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.
Montero A; Savani BN; Shenoy A; Read EJ; Carter CS; Leitman SF; Mielke S; Rezvani K; Childs R; Barrett AJ
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1318-25. PubMed ID: 17162214
[TBL] [Abstract][Full Text] [Related]
38. [Transplantation of highly purified CD34+ hematologic peripheral stem cells from haploidentical related donors in the treatment of children with non-malignant diseases].
Starý J; Sedlácek P; Vodvárková S; Poloucková A; Formánková R; Gasová Z; Marinov I
Cas Lek Cesk; 2002 Mar; 141(6):176-81. PubMed ID: 11977835
[TBL] [Abstract][Full Text] [Related]
39. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
40. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
